BR0014803A - Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição de diagnóstico - Google Patents
Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição de diagnósticoInfo
- Publication number
- BR0014803A BR0014803A BR0014803-2A BR0014803A BR0014803A BR 0014803 A BR0014803 A BR 0014803A BR 0014803 A BR0014803 A BR 0014803A BR 0014803 A BR0014803 A BR 0014803A
- Authority
- BR
- Brazil
- Prior art keywords
- amino acids
- peptides
- ser
- peptide
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
"PEPTìDEO, COMPOSIçãO FARMACêUTICA, USO DE UM OU MAIS DOS PEPTìDEOS, E, COMPOSIçãO DE DIAGNóSTICO". A invenção diz respeito a um peptìdeo modificado derivado de H-Arg-Ser-Phe-Thr-Leu-Ala-Ser-Ser-Glu-Thr-Gly-Val-Gly-OH tendo a fórmula geral (II): Q-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10-A11-A12-A13-Z. Na fórmula geral (II), A1 até A13 correspondem com os aminoácidos da Fórmula (I), Q corresponde com H e Z corresponde com OH. As modificações de acordo com a presente invenção são selecionadas de um ou mais dos grupos a, b ou c, consistindo de a) substituição de 1 a 6, preferivelmente de 1 a 4 aminoácidos em A1 até A13 com aminoácidos não naturais ou <225> aminoácidos; b) substituição de uma ou mais ligações de amida com ligações de amida reduzidas ou isósteros de etileno; c) substituições em Q e/ou Z e, opcionalmente, d) substituição de aminoácidos naturais até um total de 6 modificações. Os peptídeos podem ser usados para induzir a indução de tolerância em pacientes que sofrem de doenças autoimunes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99203427 | 1999-10-18 | ||
PCT/EP2000/010230 WO2001029081A1 (en) | 1999-10-18 | 2000-10-12 | Modified peptides and peptidomimetics for use in immunotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0014803A true BR0014803A (pt) | 2002-06-11 |
Family
ID=8240756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0014803-2A BR0014803A (pt) | 1999-10-18 | 2000-10-12 | Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição de diagnóstico |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1226167A1 (pt) |
JP (1) | JP2003512388A (pt) |
KR (1) | KR20020047245A (pt) |
CN (1) | CN1379786A (pt) |
AR (1) | AR026068A1 (pt) |
AU (1) | AU780238B2 (pt) |
BR (1) | BR0014803A (pt) |
CA (1) | CA2386398A1 (pt) |
CO (1) | CO5271650A1 (pt) |
CZ (1) | CZ20021356A3 (pt) |
HK (1) | HK1046693A1 (pt) |
HU (1) | HUP0203504A3 (pt) |
IL (1) | IL148778A0 (pt) |
MX (1) | MXPA02003520A (pt) |
NO (1) | NO20021763D0 (pt) |
NZ (1) | NZ518256A (pt) |
PE (1) | PE20010692A1 (pt) |
PL (1) | PL354590A1 (pt) |
RU (1) | RU2002113107A (pt) |
SK (1) | SK6842002A3 (pt) |
TR (1) | TR200201036T2 (pt) |
WO (1) | WO2001029081A1 (pt) |
ZA (1) | ZA200202577B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002951212A0 (en) * | 2002-09-04 | 2002-09-19 | Monash University | A method of modulating cellular activity and molecules for use therein |
WO2007117665A2 (en) * | 2006-04-06 | 2007-10-18 | Purdue Research Foundation | Derivatization-enhanced analysis of amino acids and peptides |
US20100278745A1 (en) * | 2006-12-21 | 2010-11-04 | Norbert Lange | Compounds for fluorescence imaging |
EP2245459A1 (en) | 2008-01-23 | 2010-11-03 | Herlev Hospital | Ykl-40 as a general marker for non-specific disease |
NZ592241A (en) | 2008-09-15 | 2012-11-30 | Herlev Hospital | Ykl-40 as a marker for gastrointestinal cancers |
EP3215172B1 (en) | 2014-11-07 | 2023-04-26 | Kineta Chronic Pain, Llc. | Modifications and uses of conotoxin peptides |
EP3466963A1 (en) * | 2017-10-05 | 2019-04-10 | Suigeneris Farmacosmetics, S.L. | Anticancer peptides and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL115744A (en) * | 1994-10-27 | 2000-07-16 | Akzo Nobel Nv | Peptides comprising a subsequence of human cartilage glycoprotein - 39 |
IL120561A0 (en) * | 1996-04-24 | 1997-07-13 | Akzo Nobel Nv | Peptides suitable for use in immunosuppressive therapy |
IL127332A0 (en) * | 1996-06-07 | 1999-09-22 | Zeneca Ltd | Peptide derivatives |
IL122233A (en) * | 1996-12-06 | 2001-04-30 | Akzo Nobel Nv | Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them |
-
2000
- 2000-10-12 WO PCT/EP2000/010230 patent/WO2001029081A1/en not_active Application Discontinuation
- 2000-10-12 CZ CZ20021356A patent/CZ20021356A3/cs unknown
- 2000-10-12 KR KR1020027004940A patent/KR20020047245A/ko not_active Application Discontinuation
- 2000-10-12 NZ NZ518256A patent/NZ518256A/en unknown
- 2000-10-12 EP EP00972790A patent/EP1226167A1/en not_active Withdrawn
- 2000-10-12 RU RU2002113107/15A patent/RU2002113107A/ru not_active Application Discontinuation
- 2000-10-12 AU AU11396/01A patent/AU780238B2/en not_active Ceased
- 2000-10-12 TR TR2002/01036T patent/TR200201036T2/xx unknown
- 2000-10-12 CA CA002386398A patent/CA2386398A1/en not_active Abandoned
- 2000-10-12 PL PL00354590A patent/PL354590A1/xx not_active Application Discontinuation
- 2000-10-12 BR BR0014803-2A patent/BR0014803A/pt not_active IP Right Cessation
- 2000-10-12 CN CN00814418A patent/CN1379786A/zh active Pending
- 2000-10-12 SK SK684-2002A patent/SK6842002A3/sk not_active Application Discontinuation
- 2000-10-12 MX MXPA02003520A patent/MXPA02003520A/es unknown
- 2000-10-12 IL IL14877800A patent/IL148778A0/xx unknown
- 2000-10-12 JP JP2001531879A patent/JP2003512388A/ja not_active Withdrawn
- 2000-10-12 HU HU0203504A patent/HUP0203504A3/hu unknown
- 2000-10-17 PE PE2000001107A patent/PE20010692A1/es not_active Application Discontinuation
- 2000-10-18 AR ARP000105458A patent/AR026068A1/es unknown
- 2000-10-18 CO CO00079334A patent/CO5271650A1/es not_active Application Discontinuation
-
2002
- 2002-04-02 ZA ZA200202577A patent/ZA200202577B/en unknown
- 2002-04-15 NO NO20021763A patent/NO20021763D0/no not_active Application Discontinuation
- 2002-11-13 HK HK02108208.9A patent/HK1046693A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
IL148778A0 (en) | 2002-09-12 |
HK1046693A1 (zh) | 2003-01-24 |
NZ518256A (en) | 2004-01-30 |
TR200201036T2 (tr) | 2002-08-21 |
EP1226167A1 (en) | 2002-07-31 |
CN1379786A (zh) | 2002-11-13 |
CZ20021356A3 (cs) | 2002-07-17 |
AR026068A1 (es) | 2002-12-26 |
ZA200202577B (en) | 2003-09-23 |
PE20010692A1 (es) | 2001-07-06 |
AU780238B2 (en) | 2005-03-10 |
NO20021763L (no) | 2002-04-15 |
CA2386398A1 (en) | 2001-04-26 |
MXPA02003520A (es) | 2002-08-20 |
KR20020047245A (ko) | 2002-06-21 |
JP2003512388A (ja) | 2003-04-02 |
PL354590A1 (en) | 2004-01-26 |
RU2002113107A (ru) | 2004-01-10 |
CO5271650A1 (es) | 2003-04-30 |
NO20021763D0 (no) | 2002-04-15 |
HUP0203504A3 (en) | 2005-03-29 |
SK6842002A3 (en) | 2002-09-10 |
WO2001029081A1 (en) | 2001-04-26 |
AU1139601A (en) | 2001-04-30 |
HUP0203504A2 (hu) | 2003-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950703999A (ko) | 변성된 인슐린-유사 성장인자(modified insulin-like growth factors) | |
GR3031919T3 (en) | PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES. | |
BRPI0109494B8 (pt) | muteína de fator viii, sequência de dna, vetor, processo para produção da muteína de fator viii, composição farmacêutica e uso da muteína do fator viii | |
BR9910639A (pt) | Drogas anti-angiogênicas compreendendo peptìdeo | |
BR0208183A (pt) | Peptìdeo modificado por wt1 | |
BRPI0407001A (pt) | Método para aumentar a estabilidade de uma proteìna purificada, uso de uma proteìna ligante sìtio-especìfica ativa, método para aumentar a produção de uma proteìna recombinante e composição farmacêutica | |
BR0309877A (pt) | Peptìdeos estimuladores de tecido conectivo | |
BR0011152A (pt) | Péptidos inibidores da exocitosis neurónica, composições cosméticas e farmacêuticas que os contêm | |
BR9815159A (pt) | Preparação de conjugados de polietileno glicol-grf especìfica ao sìtio | |
ATE413189T1 (de) | Verfahren und zusammensetzungen zur behinderung der vervielfältigung von hiv-1 | |
RU2012106150A (ru) | Вариантные формы уратоксидазы и их применение | |
PT593754E (pt) | Peptidos do virus do papiloma humano para uso em composicoes indutoras de uma reaccao das celulas t no homem | |
BR0209434A (pt) | Peptìdeos antimicrobianos e composições | |
BR9807618A (pt) | Análogo de fator xdelta, dna recombinante codificante para um análogo de fator xdelta, células transformadas, preparação, uso da mesma, e, processos para produzir uma preparação contendo análogo de fator xdelta recombinante purificado e análogo de fator xa. | |
BR0013638A (pt) | Novas moléculas semelhantes a interferon beta | |
BR9811755A (pt) | Peptìdeo, processo para o tratamento da obesidade em um animal, uso de um peptìdeo, e, composição farmacêutica | |
BR9607628A (pt) | Mólecula proteinácea biologicamente isolada, molécula recombinante, fragmento de peptìdeo, molécula de ácido nucleico, composição farmacêutica, e, processos para preparar uma molécula recombinante e para induzir a proliferação astroglial em um mamìfero | |
BR0111506A (pt) | Complexos de droga macromoleculares e composições contendo os mesmos | |
BR0009472A (pt) | Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas | |
PT1079849E (pt) | Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica | |
BR0014803A (pt) | Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição de diagnóstico | |
BR0116122A (pt) | Peptìdeos e/ou proteìnas bem como seu uso para preparar uma composição farmacêutica, terapêutica e/ou preventiva | |
EA199700381A1 (ru) | Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций | |
FR2846883B1 (fr) | Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide | |
ATE546461T1 (de) | Gnrh analog von nicht-säugertieren und verwendung zur regulierung der fruchtbarkeit und der schwangerschaft |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A E 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |